Phase I
October 2019 – May 2020
Measurements were completed in 102 eligible children and adolescents, aged 6 – 18 years, without respiratory disorders.
Phase II
May 2020 – August 2021 (anticipated)
Measurements in children and adolescents with asthma.
Target: 100 participants
Phase III
(anticipated) September 2021 – May 2022
Development and testing of the prediction tool.
Target: 50 children and adolescents with asthma